share_log

Biomarin Pharmaceutical | 8-K: BioMarin Announces Strong Third Quarter 2023 Results, Including Continued Profitability, and 15% Total Revenue Growth Year Over Year

拜瑪林製藥 | 8-K:BioMarin宣佈2023年第三季度強勁業績,包括持續盈利,總收入同比增長15%

SEC announcement ·  2023/11/01 16:09
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息